Technical Analysis for IGMS - IGM Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical IGMS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | 4.15% | |
| MACD Bearish Centerline Cross | Bearish | 4.15% | |
| Multiple of Ten Bearish | Other | 4.15% | |
| Wide Bands | Range Expansion | 4.15% | |
| Oversold Stochastic | Weakness | 4.15% | |
| 50 DMA Support | Bullish | -7.67% | |
| Spinning Top | Other | -7.67% | |
| Wide Bands | Range Expansion | -7.67% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Lower Bollinger Band Support | about 18 hours ago | |
| Down 3% | about 18 hours ago | |
| Down 2 % | about 18 hours ago | |
| Down 1% | about 18 hours ago | |
| Fell Below Previous Day's Low | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/24/2021
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Treatment Of Cancer Antibodies Glycoproteins Biochemistry Immunoglobulin M Protein Engineering
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Treatment Of Cancer Antibodies Glycoproteins Biochemistry Immunoglobulin M Protein Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 133.0 |
| 52 Week Low | 27.55 |
| Average Volume | 200,291 |
| 200-Day Moving Average | 70.42 |
| 50-Day Moving Average | 93.59 |
| 20-Day Moving Average | 100.00 |
| 10-Day Moving Average | 93.51 |
| Average True Range | 8.73 |
| ADX | 20.47 |
| +DI | 16.49 |
| -DI | 24.27 |
| Chandelier Exit (Long, 3 ATRs ) | 100.93 |
| Chandelier Exit (Short, 3 ATRs ) | 107.30 |
| Upper Bollinger Band | 119.95 |
| Lower Bollinger Band | 80.04 |
| Percent B (%b) | 0.19 |
| BandWidth | 39.91 |
| MACD Line | -1.46 |
| MACD Signal Line | 1.16 |
| MACD Histogram | -2.622 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 100.50 | ||||
| Resistance 3 (R3) | 99.84 | 94.84 | 98.32 | ||
| Resistance 2 (R2) | 94.84 | 91.51 | 95.16 | 97.59 | |
| Resistance 1 (R1) | 91.13 | 89.45 | 92.99 | 91.79 | 96.87 |
| Pivot Point | 86.13 | 86.13 | 87.05 | 86.45 | 86.13 |
| Support 1 (S1) | 82.42 | 82.80 | 84.28 | 83.08 | 77.99 |
| Support 2 (S2) | 77.42 | 80.74 | 77.74 | 77.27 | |
| Support 3 (S3) | 73.71 | 77.42 | 76.54 | ||
| Support 4 (S4) | 74.37 |
